Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
19.76
-0.01 (-0.05%)
At close: Aug 29, 2025, 4:00 PM
20.01
+0.25 (1.27%)
After-hours: Aug 29, 2025, 7:57 PM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $1.08 billion as of August 29, 2025. Its market cap has increased by 47.22% in one year.
Market Cap
1.08B
Enterprise Value
731.38M
1-Year Change
47.22%
Ranking
Category
Stock Price
$19.76
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $1.08B, an increase of 34.60%. That is a compound annual growth rate of 4.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 1.08B | 85.34% |
| Dec 31, 2024 | 584.23M | 148.73% |
| Dec 29, 2023 | 234.88M | -35.46% |
| Dec 30, 2022 | 363.95M | -58.77% |
| Dec 31, 2021 | 882.62M | -60.67% |
| Dec 31, 2020 | 2.24B | 142.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.11B |
| Johnson & Johnson | 422.54B |
| AbbVie | 367.30B |
| UnitedHealth Group | 273.78B |
| Novo Nordisk | 249.15B |
| AstraZeneca | 247.25B |
| Novartis AG | 245.07B |
| Abbott Laboratories | 228.64B |